A Dark Vector Cognition product

Item 16. Form 10-K Summary

23K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

None.

Index

Ameriprise Financial, Inc.

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

AMERIPRISE FINANCIAL, INC.

Registrant

Date:February 19, 2026By/s/ Walter S. Berman
Walter S. Berman Executive Vice President and Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacity and on the dates indicated.

Date:February 19, 2026By/s/ James M. Cracchiolo
James M. Cracchiolo Chairman and Chief Executive Officer (Principal Executive Officer and Director)
Date:February 19, 2026By/s/ Walter S. Berman
Walter S. Berman Executive Vice President and Chief Financial Officer (Principal Financial Officer)
Date:February 19, 2026By/s/ Dawn M. Brockman
Dawn M. Brockman Senior Vice President and Controller (Principal Accounting Officer)
Date:February 19, 2026By/s/ Dianne Neal Blixt*
Dianne Neal Blixt Director
Date:February 19, 2026By/s/ Glynis Bryan*
Glynis Bryan Director
Date:February 19, 2026By/s/ Amy DiGeso*
Amy DiGeso Director
Date:February 19, 2026By/s/ Liane J. Pelletier*
Liane J. Pelletier Director
Date:February 19, 2026By/s/ Robert F. Sharpe, Jr.*
Robert F. Sharpe, Jr. Director
Date:February 19, 2026By/s/ Brian T. Shea*
Brian T. Shea Director

Index

Ameriprise Financial, Inc.

Date:February 19, 2026By/s/ W. Edward Walter III*
W. Edward Walter III Director
Date:February 19, 2026By/s/ Christopher J. Williams*
Christopher J. Williams Director
*By/s/ Walter S. Berman
Walter S. Berman Executive Vice President and Chief Financial Officer

*Walter S. Berman, by signing his name hereto on the 19th day of February, 2026 does hereby sign this document pursuant to powers of attorney duly executed by the Directors named, filed with the Securities and Exchange Commission on behalf of such Directors as Exhibit 24 to this Form 10-K, all in the capacities and on the date stated, such persons being the majority of the Directors of the Registrant.

Index

Ameriprise Financial, Inc.

Schedule I - Condensed Financial Information of Registrant

(Parent Company Only)

Condensed Statements of Operations - Years ended December 31, 2025, 2024 and 2023166
Condensed Balance Sheets - December 31, 2025 and 2024167
Condensed Statements of Cash Flows - Years ended December 31, 2025, 2024 and 2023168
Notes to Condensed Financial Information of Registrant169

Index

Ameriprise Financial, Inc.

Schedule I — Condensed Financial Information of Registrant Condensed Statements of Operations (Parent Company Only)
Years Ended December 31,
202520242023
(in millions)
Revenues
Net investment income$78$94$77
Other revenues8115
Total revenues8610582
Banking and deposit interest expense343535
Total net revenues527047
Expenses
Distribution expenses596146
Interest and debt expense150144138
General and administrative expense253328306
Total expenses462533490
Pretax loss before equity in earnings of subsidiaries(410)(463)(443)
Income tax provision205182142
Loss before equity in earnings of subsidiaries(615)(645)(585)
Equity in earnings of subsidiaries, net of tax4,1784,0463,141
Net income3,5633,4012,556
Other comprehensive income (loss), net of tax1,016(142)780
Total comprehensive income (loss)$4,579$3,259$3,336

See Notes to Condensed Financial Information of Registrant.

Index

Ameriprise Financial, Inc.

Schedule I — Condensed Financial Information of Registrant Condensed Balance Sheets (Parent Company Only)
December 31,
20252024
(in millions, except share amounts)
Assets
Cash and cash equivalents$961$844
Investments963921
Loans to subsidiaries348343
Due from subsidiaries340273
Receivables2026
Land, buildings, equipment, and software, net of accumulated depreciation of $707 and $779, respectively301303
Investments in subsidiaries8,0246,910
Other assets1,7661,605
Total assets$12,723$11,225
Liabilities and Equity
Liabilities:
Accounts payable and accrued expenses$1,618$1,422
Due to subsidiaries354347
Borrowings from subsidiaries506756
Long-term debt3,0772,842
Other liabilities619630
Total liabilities6,1745,997
Equity:
Common shares ($0.01 par value; shares authorized, 1,250,000,000; shares issued, 338,058,287 and 337,729,050, respectively)33
Additional paid-in capital10,37710,141
Retained earnings27,66224,713
Treasury shares, at cost (246,794,407 and 241,562,357 shares, respectively)(30,601)(27,721)
Accumulated other comprehensive income (loss), net of tax, including amounts applicable to equity investments in subsidiaries(892)(1,908)
Total equity6,5495,228
Total liabilities and equity$12,723$11,225

See Notes to Condensed Financial Information of Registrant.

Index

Ameriprise Financial, Inc.

Schedule I — Condensed Financial Information of Registrant Condensed Statements of Cash Flows (Parent Company Only)
Years Ended December 31,
202520242023
(in millions)
Cash Flows from Operating Activities
Net income$3,563$3,401$2,556
Equity in earnings of subsidiaries, net of tax(4,178)(4,046)(3,141)
Dividends received from subsidiaries4,2453,7313,025
Other operating activities, primarily with subsidiaries241422453
Net cash provided by (used in) operating activities3,8713,5082,893
Cash Flows from Investing Activities
Available-for-Sale securities:
Proceeds from sales——4
Maturities, sinking fund payments and calls665543
Purchases(73)(128)(38)
Purchase of other investments——(10)
Proceeds from sales of land, buildings, equipment and software2——
Purchase of land, buildings, equipment and software(47)(59)(87)
Contributions to subsidiaries(330)(145)(324)
Return of capital from subsidiaries146351—
Repayment of loans to subsidiaries3,8583,4061,992
Issuance of loans to subsidiaries(3,863)(3,260)(2,232)
Other, net—(1)2
Net cash provided by (used in) investing activities(241)219(650)
Cash Flows from Financing Activities
Dividends paid to shareholders(596)(574)(550)
Repurchase of common shares(2,907)(2,448)(2,127)
Issuance of long-term debt, net of issuance costs741—1,335
Repayments of long-term debt(510)(561)(760)
Borrowings from subsidiaries1937261,003
Repayments of borrowings from subsidiaries(472)(586)(951)
Other, net3841(35)
Net cash provided by (used in) financing activities(3,513)(3,402)(2,085)
Net increase (decrease) in cash and cash equivalents117325158
Cash and cash equivalents at beginning of period844519361
Cash and cash equivalents at end of period$961$844$519
Supplemental Disclosures:
Interest paid on debt$142$148$129
Income taxes paid, net343179233
Federal278147193
State and local653240
New York21*14
Other state and local443226
Non-cash dividends from subsidiaries——77
  • The amount of income taxes paid during the year is below the required 5% disaggregation threshold.

See Notes to Condensed Financial Information of Registrant.

Index

Ameriprise Financial, Inc.

Schedule I — Condensed Financial Information of Registrant

Notes to Condensed Financial Information of Registrant

(Parent Company Only)

1. Basis of Presentation

The accompanying Condensed Financial Statements include the accounts of Ameriprise Financial, Inc. (the “Parent Company”) and, on an equity basis, its subsidiaries and affiliates. The Condensed Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles. The financial information of the Parent Company should be read in conjunction with the Consolidated Financial Statements and Notes of Ameriprise Financial, Inc. and its subsidiaries (“Ameriprise Financial”). Parent Company revenues and expenses, other than interest and debt expense, are primarily related to intercompany transactions with subsidiaries and affiliates.

2. Investments

On December 23, 2020, RiverSource Life Insurance Company (“RiverSource Life”) issued a $500 million unsecured 3.5% surplus note due December 31, 2050 to the Parent Company. The surplus note is subordinate in right of payment to the prior payment in full of RiverSource Life’s obligations to policyholders, claimants and beneficiaries and all other creditors. No payment of principal or interest shall be made without the prior approval of the Minnesota Department of Commerce and such payments shall be made only from RiverSource Life’s statutory surplus. Interest payments, which commenced on June 30, 2021, are due semi-annually in arrears on June 30 and December 31. Subject to the preceding conditions, RiverSource Life may prepay all or a portion of the principal at any time. The held-to-maturity investment was $500 million as of both December 31, 2025 and 2024 and is recorded in Investments on the Parent Company’s Condensed Balance Sheets. For the years ended December 31, 2025, 2024 and 2023, interest income was $18 million and is reported in Net investment income on the Parent Company’s Condensed Statements of Operations.

The Parent Company has holdings of unrated residual tranches issued by Ameriprise Installment Financing, LLC or Ameriprise Advisor Financing 2, LLC, subsidiaries of the Parent Company. The residual tranches are collateralized by portfolios of loans issued to advisors affiliated with Ameriprise Financial Services, LLC (“AFS”), a subsidiary of the Parent Company. As of December 31, 2025 and 2024, the fair value of the residual tranches was $143 million and $116 million, respectively, and is reported in Investments on the Parent Company’s Condensed Balance Sheets. Interest income from the residual tranches was $14 million, $9 million and $7 million for the year ending December 31, 2025, 2024 and 2023, respectively, and is reported in Net investment income on the Parent Company’s Condensed Statements of Operations.

3. Debt

All of the debt of Ameriprise Financial is borrowings of the Parent Company, except as indicated below.

  • As of December 31, 2025 and 2024, Ameriprise Financial had $200 million and $201 million, respectively, of borrowings from the Federal Home Loan Bank of Des Moines, which is primarily collateralized with commercial mortgage backed securities and residential mortgage backed securities.

4. Borrowings from Subsidiaries

The Parent Company has intercompany lending arrangements with its subsidiaries. At the end of each business day, taking into consideration all legal and regulatory requirements associated with its subsidiaries, the Parent Company is entitled to draw on all funds in specified bank accounts. Repayment of all or a portion of the funds is due on demand. As of December 31, 2025 and 2024, the Company had $452 million and $415 million, respectively, available for repayment due on demand. The Parent Company also has revolving credit agreements with its subsidiaries as the borrower aggregating $1.4 billion and $1.3 billion as of December 31, 2025 and 2024, respectively, of which $54 million and $340 million was outstanding as of December 31, 2025 and 2024, respectively.

5. Guarantees, Commitments and Contingencies

The Parent Company is the guarantor for operating leases of certain subsidiaries. All consolidated legal, regulatory and arbitration proceedings, including class actions of Ameriprise Financial are potential or current obligations of the Parent Company. The Parent Company has committed revolving credit agreements with its subsidiaries as the lender aggregating $365 million and $363 million as of December 31, 2025 and 2024, respectively, of which $99 million was outstanding as of both December 31, 2025 and 2024.

The Parent Company and Ameriprise Certificate Company (“ACC”) entered into a Capital Support Agreement on March 2, 2009, pursuant to which the Parent Company agrees to commit such capital to ACC as is necessary to satisfy applicable minimum capital requirements. Effective April 30, 2014, this agreement was amended to revise the maximum commitment to $50 million. For the years ended December 31, 2025, 2024 and 2023, ACC did not draw upon the Capital Support Agreement and had met all applicable capital requirements.

AFS entered into a Financial Industry Regulatory Authority (“FINRA”) approved subordinated loan agreement with the Parent Company on December 15, 2014 for regulatory net capital purposes. The agreement consists of a $200 million secured demand note. The note is secured by cash and securities equal to the principal value of the note pledged by the Parent Company. As of both December 31, 2025 and 2024, AFS had not made a demand of the principal amount.

Index

Ameriprise Financial, Inc.

American Enterprise Investment Services, Inc. (“AEIS”) entered into a FINRA approved subordinated loan agreement with the Parent Company on January 25, 2017 for regulatory net capital purposes. Under this agreement, AEIS borrowed $60 million from the Parent Company with an initial term of five years to be repaid no later than January 25, 2022. Both companies have the option to renew the agreement in one year-increments in perpetuity. The agreement was renewed in January 2022 and each year thereafter, extending the current maturity date to January 25, 2027.

6. Subsequent Events

The Parent Company made three $30 million cash contributions to Ameriprise Advisor Capital, LLC. The first occurred on January 6, 2026, the second on January 9, 2026 and the third on January 28, 2026.

Previous: Item 15. Exhibits and Financial Statement Schedules